Lower Body Mass Index is a Risk Factor for In-Hospital Mortality of Elderly Japanese Patients Treated with Ampicillin/sulbactam

Lower Body Mass Index is a Risk Factor for In-Hospital Mortality of Elderly Japanese Patients Treated with Ampicillin/sulbactam

Objectives: A retrospective examination was conducted to identify risk factors for in-hospital mortality of elderly patients (65 years or older) treated with the beta-lactam/beta-lactamase inhibitor combination antibiotic, ampicillin/sulbactam (ABPC/SBT).

Bibliographic Details
Main Authors:	Miura, Makoto, Kuwahara, Akiko, Tomozawa, Akinori, Omae, Naoki, Yamamori, Motohiro, Kadoyama, Kaori, Sakaeda, Toshiyuki
Format:	Online
Language:	English
Published:	Ivyspring International Publisher 2016
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5069409/

Similar Items

AMPICILLIN SULBACTAM AND CEFOTAXIME ARE SIMILARLY EFFECTIVE IN PEDIATRIC PNEUMONIA
by: Diny Puspitasari, et al.
Published: (2017-08-01)

Hypersensitivity reactions to anticancer agents: Data mining of the public version of the FDA adverse event reporting system, AERS
by: Kadoyama, Kaori, et al.
Published: (2011)

Effects of plasma concentrations of 5-fluorouracil on long-term survival after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma
by: Kuwahara, Akiko, et al.
Published: (2011)

The minimal inhibitory concentration for sulbactam was not associated with the outcome of infections caused by carbapenem-resistant Acinetobacter sp. treated with ampicillin/sulbactam
by: de Oliveira, Maura S., et al.
Published: (2013)

AMPICILLIN SULBACTAM RESISTANCE PATTERN AS A FIRST-LINE DRUG IN CHILDREN
by: Oka Putrawan, et al.
Published: (2016-11-01)

Effects of Bolus Injection of 5-Fluorouracil on Steady-State Plasma Concentrations of 5-Fluorouracil in Japanese Patients with Advanced Colorectal Cancer
by: Tamura, Takao, et al.
Published: (2011)

Effects of Bolus Injection of 5-Fluorouracil on Steady-State Plasma Concentrations of 5-Fluorouracil in Japanese Patients with Advanced Colorectal Cancer
by: Takao Tamura, Akiko Kuwahara, Kaori Kadoyama, Motohiro Yamamori, Kohshi Nishiguchi, Tsubasa Inokuma, Yoshiji Takemoto, Naoko Chayahara, Tatsuya Okuno, Ikuya Miki, Yoshimi Fujishima, Toshiyuki Sakaeda
Published: (2011-01-01)

Effect of dose-escalation of 5-fluorouracil on circadian variability of its pharmacokinetics in Japanese patients with Stage III/IVa esophageal squamous cell carcinoma
by: Akiko Kuwahara, Motohiro Yamamori, Kohshi Nishiguchi, Tatsuya Okuno, Naoko Chayahara, Ikuya Miki, Takao Tamura, Kaori Kadoyama, Tsubasa Inokuma, Yoshiji Takemoto, Tsutomu Nakamura, Kazusaburo Kataoka, Toshiyuki Sakaeda
Published: (2010-01-01)

Data Mining of the Public Version of the FDA Adverse Event Reporting System
by: Sakaeda, Toshiyuki, et al.
Published: (2013)

T.E.A. Study: three-day ertapenem versus three-day Ampicillin-Sulbactam
by: Catena, Fausto, et al.
Published: (2013)

A randomized trial of tigecycline versus ampicillin-sulbactam or amoxicillin-clavulanate for the treatment of complicated skin and skin structure infections
by: Matthews, Peter, et al.
Published: (2012)

Role of ampicillin-sulbactam: a district hospital's experience in treating diabetic foot ulcers
by: Nurul Nadiah Zainal Abidin
Published: (2012)

Statin-Associated Muscular and Renal Adverse Events: Data Mining of the Public Version of the FDA Adverse Event Reporting System
by: Sakaeda, Toshiyuki, et al.
Published: (2011)

Adverse Event Profiles of Platinum Agents: Data Mining of the Public Version of the FDA Adverse Event Reporting System, AERS, and Reproducibility of Clinical Observations
by: Sakaeda, Toshiyuki, et al.
Published: (2011)

Adverse Event Profiles of Platinum Agents: Data Mining of the Public Version of the FDA Adverse Event Reporting System, AERS, and Reproducibility of Clinical Observations
by: Toshiyuki Sakaeda, Kaori Kadoyama, Yasushi Okuno
Published: (2011-01-01)

VEGF -634C/G Genotype is Predictive of Long-term Survival after Treatment with a Definitive 5-Fluorouracil/cisplatin-based Chemoradiotherapy in Japanese Patients with Esophageal Squamous Cell Carcinoma
by: Tamura, Takao, et al.
Published: (2012)

VEGF -634C/G Genotype is Predictive of Long-term Survival after Treatment with a Definitive 5-Fluorouracil/cisplatin-based Chemoradiotherapy in Japanese Patients with Esophageal Squamous Cell Carcinoma
by: Takao Tamura, Akiko Kuwahara, Motohiro Yamamori, Kohshi Nishiguchi, Tsutomu Nakamura, Tatsuya Okuno, Ikuya Miki, Yuki Manabe, Toshiyuki Sakaeda
Published: (2012-01-01)

A prospective, multi centre, randomized clinical study to compare the efficacy and safety of Ertapenem 3 days versus Ampicillin - Sulbactam 3 days in the treatment of localized community acquired intra-abdominal infection. (T.E.A. Study: Three days Ertapenem vs three days Ampicillin-sulbactam)
by: Coccolini, Federico, et al.
Published: (2011)

VEGF T-1498C polymorphism, a predictive marker of differentiation of colorectal adenocarcinomas in Japanese
by: Motohiro Yamamori, Mayuko Taniguchi, Shingo Maeda, Tsutomu Nakamura, Noboru Okamura, Akiko Kuwahara, Koichi Iwaki, Takao Tamura, Nobuo Aoyama, Svetlana Markova, Masato Kasuga, Katsuhiko Okumura, Toshiyuki Sakaeda
Published: (2008-01-01)

Replacement of cisplatin with nedaplatin in a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma
by: Akiko Kuwahara, Motohiro Yamamori, Kohshi Nishiguchi, Tatsuya Okuno, Naoko Chayahara, Ikuya Miki, Takao Tamura, Tsubasa Inokuma, Yoshiji Takemoto, Tsutomu Nakamura, Kazusaburo Kataoka, Toshiyuki Sakaeda
Published: (2009-01-01)

A Survey of the FAERS Database Concerning the Adverse Event Profiles of α1-Adrenoreceptor Blockers for Lower Urinary Tract Symptoms
by: Yoshimura, Koji, et al.
Published: (2013)

Aspirin- and Clopidogrel-associated Bleeding Complications: Data Mining of the Public Version of the FDA Adverse Event Reporting System, AERS
by: Tamura, Takao, et al.
Published: (2012)

Omeprazole- and Esomeprazole-associated Hypomagnesaemia: Data Mining of the Public Version of the FDA Adverse Event Reporting System
by: Tamura, Takao, et al.
Published: (2012)

Commonality of Drug-associated Adverse Events Detected by 4 Commonly Used Data Mining Algorithms
by: Sakaeda, Toshiyuki, et al.
Published: (2014)

Aspirin- and Clopidogrel-associated Bleeding Complications: Data Mining of the Public Version of the FDA Adverse Event Reporting System, AERS
by: Takao Tamura, Toshiyuki Sakaeda, Kaori Kadoyama, Yasushi Okuno
Published: (2012-01-01)

Omeprazole- and Esomeprazole-associated Hypomagnesaemia: Data Mining of the Public Version of the FDA Adverse Event Reporting System
by: Takao Tamura, Toshiyuki Sakaeda, Kaori Kadoyama, Yasushi Okuno
Published: (2012-01-01)

Incidence of postpartum endomyometritis following single-dose antibiotic prophylaxis with either ampicillin/sulbactam, cefazolin, or cefotetan in high-risk cesarean section patients.
by: Noyes, N, et al.
Published: (1998)

Genetic Polymorphisms in SLC23A2 as Predictive Biomarkers of Severe Acute Toxicities after Treatment with a Definitive 5-Fluorouracil/Cisplatin-Based Chemoradiotherapy in Japanese Patients with Esophageal Squamous Cell Carcinoma
by: Minegaki, Tetsuya, et al.
Published: (2014)

Hypersensitivity vasculitis induced by cefoperazone/sulbactam
by: Islek, Ismail, et al.
Published: (2003)

A multicentre clinical study on the injection of ceftriaxone/sulbactam compared with cefoperazone/sulbactam in the treatment of respiratory and urinary tract infections
by: Xin, Xiaojuan, et al.
Published: (2013)

Effectiveness of Ampicillin and Ampicillin-Gentamicin for Children under Five Years Old with Pneumonia
by: Salma H. California, et al.
Published: (2018-03-01)

Sulbactam-enhanced cytotoxicity of doxorubicin in breast cancer cells
by: Shao-hsuan Wen, et al.
Published: (2018-09-01)

Serum Lactate Dehydrogenase Levels as a Predictive Marker of Oxaliplatin-Induced Hypersensitivity Reactions in Japanese Patients with Advanced Colorectal Cancer
by: Seki, Kyoko, et al.
Published: (2014)

Adverse Event Profiles of 5-Fluorouracil and Capecitabine: Data Mining of the Public Version of the FDA Adverse Event Reporting System, AERS, and Reproducibility of Clinical Observations
by: Kadoyama, Kaori, et al.
Published: (2011)

Platinum Agent-Induced Hypersensitivity Reactions: Data Mining of the Public Version of the FDA Adverse Event Reporting System, AERS
by: Sakaeda, Toshiyuki, et al.
Published: (2011)

Platinum Agent-Induced Hypersensitivity Reactions: Data Mining of the Public Version of the FDA Adverse Event Reporting System, AERS
by: Toshiyuki Sakaeda, Kaori Kadoyama, Hiroaki Yabuuchi, Satoshi Niijima, Kyoko Seki, Yukinari Shiraishi, Yasushi Okuno
Published: (2011-01-01)

Adverse Event Profiles of 5-Fluorouracil and Capecitabine: Data Mining of the Public Version of the FDA Adverse Event Reporting System, AERS, and Reproducibility of Clinical Observations
by: Kaori Kadoyama, Ikuya Miki, Takao Tamura, JB Brown, Toshiyuki Sakaeda, Yasushi Okuno
Published: (2012-01-01)

THRB Genetic Polymorphisms Can Predict Severe Myelotoxicity after Definitive Chemoradiotherapy in Patients with Esophageal Squamous Cell Carcinoma
by: Miki, Ikuya, et al.
Published: (2012)

THRB Genetic Polymorphisms Can Predict Severe Myelotoxicity after Definitive Chemoradiotherapy in Patients with Esophageal Squamous Cell Carcinoma
by: Ikuya Miki, Tsutomu Nakamura, Akiko Kuwahara, Motohiro Yamamori, Kohshi Nishiguchi, Takao Tamura, Tatsuya Okuno, Hideaki Omatsu, Shigeto Mizuno, Midori Hirai, Takeshi Azuma, Toshiyuki Sakaeda
Published: (2012-01-01)

Synthesis and biological activity of ampicillin derivatives
by: Liak, Amanda Man Dee
Published: (2012)